ATE399544T1 - Synergistische zusammensetzung enthaltend roflumilast und (r,r)-formoterol - Google Patents

Synergistische zusammensetzung enthaltend roflumilast und (r,r)-formoterol

Info

Publication number
ATE399544T1
ATE399544T1 AT03780056T AT03780056T ATE399544T1 AT E399544 T1 ATE399544 T1 AT E399544T1 AT 03780056 T AT03780056 T AT 03780056T AT 03780056 T AT03780056 T AT 03780056T AT E399544 T1 ATE399544 T1 AT E399544T1
Authority
AT
Austria
Prior art keywords
formoterol
composition containing
synergistic composition
containing roflumilast
roflumilast
Prior art date
Application number
AT03780056T
Other languages
German (de)
English (en)
Inventor
Rolf Beume
Daniela Bundschuh
Degenhard Marx
Christian Weimar
Stefan-Lutz Wollin
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Application granted granted Critical
Publication of ATE399544T1 publication Critical patent/ATE399544T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03780056T 2002-11-27 2003-11-26 Synergistische zusammensetzung enthaltend roflumilast und (r,r)-formoterol ATE399544T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02026504 2002-11-27

Publications (1)

Publication Number Publication Date
ATE399544T1 true ATE399544T1 (de) 2008-07-15

Family

ID=32338001

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03780056T ATE399544T1 (de) 2002-11-27 2003-11-26 Synergistische zusammensetzung enthaltend roflumilast und (r,r)-formoterol

Country Status (31)

Country Link
US (1) US20060199865A1 (cg-RX-API-DMAC7.html)
EP (1) EP1567140B1 (cg-RX-API-DMAC7.html)
JP (1) JP2006508993A (cg-RX-API-DMAC7.html)
KR (1) KR20050094810A (cg-RX-API-DMAC7.html)
CN (1) CN1713902A (cg-RX-API-DMAC7.html)
AT (1) ATE399544T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003288169B8 (cg-RX-API-DMAC7.html)
BR (1) BR0316475A (cg-RX-API-DMAC7.html)
CA (1) CA2506956C (cg-RX-API-DMAC7.html)
CO (1) CO5690571A2 (cg-RX-API-DMAC7.html)
CY (1) CY1110368T1 (cg-RX-API-DMAC7.html)
DE (1) DE60321954D1 (cg-RX-API-DMAC7.html)
DK (1) DK1567140T3 (cg-RX-API-DMAC7.html)
EA (1) EA009990B1 (cg-RX-API-DMAC7.html)
ES (1) ES2309374T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20050580B1 (cg-RX-API-DMAC7.html)
IL (1) IL168307A (cg-RX-API-DMAC7.html)
IS (1) IS2576B (cg-RX-API-DMAC7.html)
MA (1) MA27538A1 (cg-RX-API-DMAC7.html)
ME (1) ME00488B (cg-RX-API-DMAC7.html)
MX (1) MXPA05005438A (cg-RX-API-DMAC7.html)
NO (1) NO334148B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ540658A (cg-RX-API-DMAC7.html)
PL (1) PL214869B1 (cg-RX-API-DMAC7.html)
PT (1) PT1567140E (cg-RX-API-DMAC7.html)
RS (1) RS51082B (cg-RX-API-DMAC7.html)
SI (1) SI1567140T1 (cg-RX-API-DMAC7.html)
TN (1) TNSN05130A1 (cg-RX-API-DMAC7.html)
UA (1) UA83017C2 (cg-RX-API-DMAC7.html)
WO (1) WO2004047828A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200503307B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
ME00524B (me) 2003-03-10 2011-10-10 Astrazeneca Ab Novi postupak za dobijanje roflumilasta
EP1861074B1 (en) 2005-03-16 2013-04-24 Takeda GmbH Taste masked dosage form containing roflumilast
WO2013077830A1 (en) * 2011-11-25 2013-05-30 Mahmut Bilgic Synergistilly active combinations of roflumilast and carmoterol
CN103784443A (zh) * 2014-02-18 2014-05-14 青岛市城阳区人民医院 一种包含沙美特罗和罗氟司特的药物组合产品

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
EP0938467B1 (en) * 1996-11-11 2002-06-12 Sepracor, Inc. Process for the preparation of optically pure isomers of formoterol
EA001758B1 (ru) * 1997-02-17 2001-08-27 Бык Гульден Ломберг Хемише Фабрик Гмбх Композиции для лечения респираторного дистресс-синдрома взрослых или респираторного дистресс-синдрома новорожденных, содержащие 3-(циклопропилметокси)-n-(3,5-дихлор-4-пиридинил)-4-(дифторметокси)бензамид и легочное поверхностно-активное вещество
US6333354B1 (en) * 1997-02-28 2001-12-25 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of PDE inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
BR9913152A (pt) * 1998-08-26 2001-05-15 Smithkline Beecham Corp Terapias para tratamento de doenças pulmonares
US6303145B2 (en) * 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
EP1671651B1 (en) * 1999-08-21 2009-11-11 Nycomed GmbH Synergistic combination of pumafentrine and salmeterol
GB0103630D0 (en) * 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
ATE381537T1 (de) * 2001-03-22 2008-01-15 Glaxo Group Ltd Formanilid-derivative als beta2-adrenorezeptor- agonisten
ES2314052T3 (es) * 2001-04-30 2009-03-16 Glaxo Group Limited Derivados de ester de 17beta-carbotioato de androstano con un grupo ester ciclico en la posicion 17alfa.

Also Published As

Publication number Publication date
EA200500865A1 (ru) 2005-12-29
EA009990B1 (ru) 2008-04-28
MXPA05005438A (es) 2005-08-03
US20060199865A1 (en) 2006-09-07
AU2003288169B2 (en) 2010-01-07
MA27538A1 (fr) 2005-09-01
CA2506956A1 (en) 2004-06-10
KR20050094810A (ko) 2005-09-28
AU2003288169B8 (en) 2010-08-26
AU2003288169A1 (en) 2004-06-18
BR0316475A (pt) 2005-10-11
NO20053023L (no) 2005-06-20
PT1567140E (pt) 2008-09-24
ME00488B (me) 2011-10-10
RS51082B (sr) 2010-10-31
DE60321954D1 (de) 2008-08-14
PL214869B1 (pl) 2013-09-30
EP1567140A1 (en) 2005-08-31
IL168307A (en) 2010-12-30
ES2309374T3 (es) 2008-12-16
RS20050383A (sr) 2007-08-03
IS7899A (is) 2005-06-20
SI1567140T1 (sl) 2008-12-31
CY1110368T1 (el) 2015-04-29
CN1713902A (zh) 2005-12-28
IS2576B (is) 2010-02-15
HRP20050580A2 (en) 2006-08-31
TNSN05130A1 (en) 2007-05-14
WO2004047828A1 (en) 2004-06-10
EP1567140B1 (en) 2008-07-02
HK1081862A1 (en) 2006-05-26
JP2006508993A (ja) 2006-03-16
CA2506956C (en) 2012-10-02
PL375632A1 (en) 2005-12-12
DK1567140T3 (da) 2008-11-03
NZ540658A (en) 2007-03-30
ZA200503307B (en) 2006-11-29
UA83017C2 (uk) 2008-06-10
NO334148B1 (no) 2013-12-16
CO5690571A2 (es) 2006-10-31
HRP20050580B1 (hr) 2014-04-11

Similar Documents

Publication Publication Date Title
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
DE60331236D1 (de) Orale zusammensetzungen zur behandlung von diabetes
NO20050807L (no) Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser
ATE320800T1 (de) Synergistische kombination von roflumilast und salmeterol
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
CY1110369T1 (el) Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη
MXPA05012358A (es) Combinacion farmaceutica que comprende modafinilo y otra droga.
CY1110368T1 (el) Συνεργιστικος συνδυασμος ο οποιος περιλαμβανει ροφλουμιλαστη και (r,r)-φορμοτερολη
CY1106552T1 (el) Ενωσεις ισοχρωμανιου για την θεραπεια ανωμαλιων του κνς
TWI347845B (en) Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1567140

Country of ref document: EP